Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial...
Month: September 2024
AI/ML Innovations Inc. Provides Second Status Update
TORONTO, ON / ACCESSWIRE / September 20, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that further to its...
Leafbuyer Technologies, Inc. Announces Quarterly Results
16.4% Increase in Year Over Year Revenue Growth and a 9% increase in Gross profit DENVER, CO / ACCESSWIRE /...
Dr. Vitenas Provides Insight Into Emerging ‘Yoga’ or ‘Ballerina’ Breast Augmentation Trend
Dr. Paul Vitenas Unveils 'Yoga Boobs' Trend for Natural, Athletic Breast Augmentation Using Cutting-Edge TechniquesHOUSTON, TX / ACCESSWIRE / September...
HandicapMD Expands Leading Telemedicine Services for Disabled Parking Permits in Florida
HandicapMD's virtual telemedicine platform connects patients with licensed doctors to obtain disabled parking placards quickly, safely, and affordably. MIAMI, Sept....
NewSound’s Commitment to Medical Device Excellence: MDD, MDR, and Beyond
XIAMEN, China, Sept. 20, 2024 /PRNewswire/ -- Founded in 2004, the whole family of NewSound has been devoting to offering...
ISI Technology Makes Inc. 5000 List for the Second Consecutive Year
BUFFALO, N.Y., Sept. 20, 2024 /PRNewswire/ -- ISI Technology, a leading provider of software solutions for Non-Emergency Medical Transportation (NEMT)...
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it...
XpertDox Partners with Blue Fish Pediatrics to Enhance Medical Coding Efficiency with AI-Powered Healthcare Coding Software
XpertDox and Blue Fish Pediatrics Join Forces to Streamline Medical Coding, Enhance Clinical Documentation, and Boost Reimbursement Potential PHOENIX, Sept....
This Week in Health News: 11 Stories You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the latest FDA approvals, health...
BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or...
NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company...
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare...
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product – Aversa(TM) Fentanyl Transdermal Patch
Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive...
Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade
European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary cholangitis (PBC), a rare liver...
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant,...
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused...
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
THE WOODLANDS, TX, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
-Trial to focus on particularly vulnerable subset of patients, following strong clinician interest in use of the Alpha DaRT in...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age...